CLINICAL_TRIALS
trial_result
· 2026-06-03
Clinical Trial Results: Apremilast for Erythema Multiforme [Phase 2]
Summary
Phase 2 clinical trial results for apremilast in erythema multiforme have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Robert Micheletti | Conditions: Erythema Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2026-06-03